Amgen has finally closed its $27.8 billion takeover of Horizon Pharma, which was held up for several months by opposition from financial regulators. The company confirmed that it had completed the ...

Meanwhile, Amgen’s offer price is at an approximately 20% premium to Horizon’s closing price of €92.48 ($97.29) on Friday 9 th December. Californian biotech Amgen’s own market value is ...

Amgen's keen emphasis on acquiring and integrating high-potential businesses has paved the way for significant expansion. The integration of Horizon Therapeutics (acquired in October 2023), known ...